Vomocytosis of live pathogens from macrophages is regulated by the atypical MAP kinase ERK5

DSpace/Manakin Repository

Vomocytosis of live pathogens from macrophages is regulated by the atypical MAP kinase ERK5

Citable link to this page

 

 
Title: Vomocytosis of live pathogens from macrophages is regulated by the atypical MAP kinase ERK5
Author: Gilbert, Andrew S.; Seoane, Paula I.; Sephton-Clark, Poppy; Bojarczuk, Aleksandra; Hotham, Richard; Giurisato, Emanuele; Sarhan, Adil R.; Hillen, Amy; Velde, Greetje Vande; Gray, Nathanael S.; Alessi, Dario R.; Cunningham, Debbie L.; Tournier, Cathy; Johnston, Simon A.; May, Robin C.

Note: Order does not necessarily reflect citation order of authors.

Citation: Gilbert, A. S., P. I. Seoane, P. Sephton-Clark, A. Bojarczuk, R. Hotham, E. Giurisato, A. R. Sarhan, et al. 2017. “Vomocytosis of live pathogens from macrophages is regulated by the atypical MAP kinase ERK5.” Science Advances 3 (8): e1700898. doi:10.1126/sciadv.1700898. http://dx.doi.org/10.1126/sciadv.1700898.
Full Text & Related Files:
Abstract: Vomocytosis, or nonlytic extrusion, is a poorly understood process through which macrophages release live pathogens that they have failed to kill back into the extracellular environment. Vomocytosis is conserved across vertebrates and occurs with a diverse range of pathogens, but to date, the host signaling events that underpin expulsion remain entirely unknown. We use a targeted inhibitor screen to identify the MAP kinase ERK5 as a critical suppressor of vomocytosis. Pharmacological inhibition or genetic manipulation of ERK5 activity significantly raises vomocytosis rates in human macrophages, whereas stimulation of the ERK5 signaling pathway inhibits vomocytosis. Lastly, using a zebrafish model of cryptococcal disease, we show that reducing ERK5 activity in vivo stimulates vomocytosis and results in reduced dissemination of infection. ERK5 therefore represents the first host signaling regulator of vomocytosis to be identified and a potential target for the future development of vomocytosis-modulating therapies.
Published Version: doi:10.1126/sciadv.1700898
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559206/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34375284
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters